1
Terry L Burkoth, Lina T Taskovich, Russell D Beste, Robert M Gale, Eun Soo Lee, Richard D Hamlin, Su LL Yum: Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate. ALZA Corporation, Michael J Rafa, Steve F Stone, December 1, 1998: US05843468 (45 worldwide citation)

Compositions, devices, and methods for transdermal administration of an active agent are disclosed using a novel dual permeation enhancer mixture comprising lauryl acetate and a monoglyceride, preferably glycerol monolaurate. The dual permeation enhancer mixture comprising lauryl acetate is a potent ...


2
Russell D Beste, Richard D Hamlin: Skin permeation enhancer compositions comprising a monoglyceride and ethyl palmitate. ALZA Corporation, Vandana Date, Steven Stone, July 31, 2001: US06267984 (32 worldwide citation)

Compositions, devices, and methods for transdermal administration of a drug are disclosed using a novel permeation enhancer mixture comprising a monoglyceride and ethyl palmitate. The monoglyceride/ethyl palmitate permeation enhancer is a potent permeation enhancer and provides stable systems which ...


3
Richard D Hamlin, Amit Jain, Jianye Wen: Propynylaminoindan transdermal compositions. Teikoku Pharma USA, Bret E Field, Khin K Chin, Bozicevic Field & Francis, December 8, 2015: US09205061 (1 worldwide citation)

Propynylaminoindan (e.g., Rasagiline) transdermal compositions are provided. Aspects of the transdermal compositions include a matrix which includes the propynylaminoindan, a pressure sensitive adhesive that includes an acrylate copolymer and a cationic acrylic copolymer. Also provided are methods o ...


4
Richard D Hamlin, Amit Jain, Jianye Wen: Propynylaminoindan transdermal compositions. Teikoku Pharma USA, Khin K Chin, Bret E Field, Bozicevic Field & Francis, November 28, 2017: US09827207

Propynylaminoindan (e.g., Rasagiline) transdermal compositions are provided. Aspects of the transdermal compositions include a matrix which includes the propynylaminoindan, a pressure sensitive adhesive that includes an acrylate copolymer and a cationic acrylic copolymer. Also provided are methods o ...


5
Jianye Wen, Richard D Hamlin: Propynylaminoindan transdermal compositions. Teikoku Pharma USA, Khin K Chin, Bret E Field, Bozicevic Field & Francis, March 21, 2017: US09597301

Propynylaminoindan (e.g., Rasagiline) transdermal compositions are provided. Aspects of the transdermal compositions include a matrix of the propynylaminoindan in a pressure sensitive adhesive comprising a carboxylated polymer. In some instances, the matrix further includes a cationic acrylic copoly ...


6
Susan Meier Davis, Jianye Wen, Richard D Hamlin: Methods for the treatment of skin neoplasms. Teikoku Pharma USA, Otto C Guedelhoefer IV, Bret E Field, Bozicevic Field & Francis, March 13, 2018: US09913812

Methods of treating skin neoplasms using a monoamine oxidase inhibitor, e.g., a propynylaminoindan (such as rasagiline) are provided. Pharmaceutical compositions and kits comprising monoamine oxidase inhibitors are also provided.


7
Subramanian S Venkatraman, Thomas M Stein, James Snider, Richard D Hamlin: Transdermal drug delivery devices comprising a polyurethane drug reservoir. Philip S Johnson, Johnson & Johnson, March 3, 2005: US20050048104-A1

The present invention relates to the field of transdermal drug delivery. More specifically, the present invention relates to drug reservoir materials for use in transdermal drug delivery devices. The drug reservoirs of the present invention comprise a polyurethane polymer which can be processed at t ...


8